VerifiedBiotechnology Research· Founded 2021

Hillevax

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.

7-day free trial · no credit card

HeadquartersBoston, United StatesEmployees92(51 to 200)Founded year2021Websitehillevax.comLinkedIn profileLinkedIn

Verified contacts

35

available on Kipplo

LinkedIn employees

92

51 to 200 range

Open roles

no listings

Distinct roles

25

indexed titles

Tech stack

0

tools in use

Monthly traffic

199

organic / mo

Sign up free to see all 35 verified contacts at Hillevax

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

35 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Hillevax

25 distinct titles indexed · top 10 shown.

  • 2executive assistant
  • 1associate director program management technical scientific writing analytical development
  • 1associate director supply chain and procurement
  • 1chief financial officer
  • 1chief medical officer
  • 1clinical project manager
  • 1csv consultant
  • 1director, clinical project management
  • 1director, manufacturing science & technology
  • 1executive director, evidence generation
  • +15more titles

Sign up to unlock all 35 contacts at Hillevax

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 35 verified contacts at Hillevax

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Hillevax | Kipplo Discover